NHS England and NICE have approved the use of Tirzepatide, which you may also know as Mounjaro ® from primary care from 23rd June 2025. However, in the first two years entry criteria has been set by NHS England to a very small number of people. This is to allow safe entry of this repurposed medicine into the health system.
Please only contact us if you are eligible. The eligibility criteria:
- BMI of 40 or higher
And at least 4 of the following conditions:
- Type 2 diabetes mellitus
- Hypertension
- Dyslipidaemia
- Obstructive sleep apnoea
- Atherosclerotic Cardiovascular Disease (ASCVD)